Search Results for "Galderma Company Rpofile"

10:56 EST 28th February 2015 | BioPortfolio

Matching Channels

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Galderma earns wrath of PMCPA in unprecedented case

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely concerning’ breaches were made by the firm.  The PMCPA, whic...

Merck and Galderma breach ABPI code

Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code of Practice. The PMCPA, which polices the ABPI’s Code of Practice in the UK, reports t...

FDA approves Galderma’s Soolantra Cream for Rosacea patients

Galderma Laboratories announced that the U.S. Food and Drug Administration (FDA) approved Soolantra® (ivermectin) Cream, 1% for the once-daily topical treatment of inflammatory lesions, or bumps and ...

Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea

FORT WORTH, Texas, December 23, 2014 --(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) approved Soolantra (ivermectin) Cream, 1% for the o...

Galderma makes Soolantra Cream, 1% available in US for rosacea patients

Galderma Laboratories has launched Soolantra (ivermectin) Cream, 1% , a once-daily, antibiotic-free, prescription topical treatment for rosacea patients in the US.

Galderma launches first OTC acne regimen Benzac Acne solutions

Galderma Laboratories, maker of Cetaphil and the #1 prescription topical acne brand, announced the launch of Benzac Acne Solutions, its first-ever, over-the-counter (OTC) acne regimen.

Galderma sales and marketing update

Galderma Initiates U.S. Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgery

Galderma, a global healthcare company focused on dermatology, today announced that it has initiated a Phase II clinical trial of a novel muscle relaxant in the United States. The ...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement